Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $25.01, for a total value of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares in the company, valued at $3,289,640.33. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Aspen Aerogels Stock Up 0.4 %
NYSE:ASPN opened at $26.73 on Friday. The company has a current ratio of 4.01, a quick ratio of 3.29 and a debt-to-equity ratio of 0.24. The stock has a 50 day moving average of $17.46 and a 200-day moving average of $14.22. The firm has a market capitalization of $2.04 billion, a PE ratio of -60.75 and a beta of 1.97. Aspen Aerogels, Inc. has a 52 week low of $5.32 and a 52 week high of $27.19.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. The firm had revenue of $84.22 million during the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same period in the prior year, the business earned ($0.20) EPS. Analysts predict that Aspen Aerogels, Inc. will post 0.03 EPS for the current year.
Institutional Trading of Aspen Aerogels
Analyst Ratings Changes
ASPN has been the subject of a number of recent analyst reports. Piper Sandler raised their price target on shares of Aspen Aerogels from $20.00 to $29.00 and gave the stock an “overweight” rating in a research report on Friday, May 3rd. B. Riley raised their price objective on shares of Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Roth Mkm restated a “buy” rating and issued a $22.00 target price on shares of Aspen Aerogels in a research note on Tuesday, April 30th. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. Finally, HC Wainwright boosted their price target on Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $25.17.
Check Out Our Latest Stock Report on ASPN
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More
- Five stocks we like better than Aspen Aerogels
- Energy and Oil Stocks Explained
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is a Dividend King?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is the S&P/TSX Index?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.